ClinicalTrials.gg
WithdrawnNCT07148479Updated Aug 27, 2026

Telerehabilitation Versus Traditional Balance Training in Women With Osteoporosis.

An interventional study of Telerehabilitation group and Traditional balance training group in Osteoporosis Postmenopausal, sponsored by Riphah International University. Withdrawn at 1 site in Pakistan. Open to female participants aged 50 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

Why this study was withdrawn
Unavailability of patients and other resources to the researchers

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
50 Years to 70 Years
Sex
Female
01

Study summary

Osteoporosis is a silent disease that leads to fractures, postural deformities, and impaired balance, especially in postmenopausal women. In Pakistan, prevalence is high, with 39% of women reported as severely osteoporotic. Postmenopausal women with osteoporosis and balance issues face increased fall risk due to poor bone density, weakened muscles especially in the lower limb band altered posture .Balance and strength training reduce fall risk, but access to in-person rehabilitation is limited. Telerehabilitation provides remote delivery of structured exercise programs and has shown positive outcomes in balance and bone health. Few studies, however, have compared telerehabilitation with conventional training across all balance domains. The goal of this randomized controlled trial is to compare the effect of Telerehabilitation and Traditional Balance Training in Post Menopausal Women with osteoporosis. Participants will be randomly assigned to one of the two groups, and both will receive an identical standardized balance training program . The results of this clinical trial will help evaluate how telerehabilitation can improve the balance of postmenopausal women with osteoporosis and improve health outcomes.

Read the detailed description

Osteoporosis often remains undetected until fractures occur, typically involving the hip, wrist, or spine, and may also cause back pain, height loss, and kyphosis. Postmenopausal women face increased fall risk due to reduced bone density, weakened lower limb muscles, and altered posture. Many also develop fear of falling, which restricts activity and accelerates muscle weakness.

Globally, osteoporosis affects about 23.1% of women and 11.7% of men, with fragility fractures being a major cause of disability. In Pakistan, hospital-based findings show a high proportion of postmenopausal women as severely osteoporotic, with a strong link to fall-related injuries.

Exercise interventions, including balance, resistance, and weight-bearing training, are known to improve bone strength, postural control, and confidence by stimulating bone remodelling and enhancing musculoskeletal performance. Telerehabilitation, delivered via video conferencing, provides remote access to such programs and has demonstrated improvements in stability, weight-shifting, and functional balance.

However, most studies assess limited outcomes using tools like TUG or BBS, without addressing static, dynamic, anticipatory, and reactive balance together. Evidence largely comes from high-income countries, while data from resource-limited settings like Pakistan remain scarce. This trial seeks to evaluate telerehabilitation compared to traditional training across comprehensive balance domains in postmenopausal women with osteoporosis.

02

Conditions studied

  • Osteoporosis Postmenopausal

Keywords

  • Telerehabilitation
  • Balance
  • Osteoporosis
  • Posmenopausal
  • Virtual exercise
03

In context

Osteoporosis, Postmenopausal

334 studies on the registry are indexed under Osteoporosis, Postmenopausal; 28 are open to participants now.

Browse Osteoporosis, Postmenopausal studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,201 studies on the registry; 647 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Women diagnosed with osteopenia and osteoporosis at hip and lumbar spine through DEXA

      • Age 50-70 years
      • Have mobile phones and can communicate in video call
      • Have Balance score (21-44) on berg balance scale
      • A caregiver must be available to assist the participant during Tele sessions.

Exclusion criteria

Exclusion Criteria:

    • Women with severe mobility impairments.

      • Women with cognitive conditions affecting participation.
      • Women with lower limb joint injury or surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Telerehabilitation group

    This group will receive a 6 week structured telerehabilitation exercise protocol of low to moderate intensity (18 sessions , 3 sessions per week,45 to 60 minutes ), warmup, balance training and cool down exercises. delivered online by a physiotherapist and progressively increasing every three weeks.

    Other: Telerehabilitation group

  • Active comparator
    Traditional Balance Training group

    In the traditional balance training group the protocol will be delivered by a physiotherapist in a clinical environment face to face. The standardized balance training protocol will be monitored exactly the same as telerehabilitation group

    Other: Traditional balance training group

Interventions

  • OtherTelerehabilitation group

    The telerehabilitation group participated in balance training sessions delivered through secure virtual platforms such as WhatsApp video calls. Participants completed 3 sessions per week, each lasting 45-60 minutes, over a total of 6 weeks (18 sessions). The program target static, dynamic, anticipatory, and reactive balance. participants will use households items.session began with warm-up exercises such as gentle marching, arm circles, and hamstring stretches, followed by balance training targeting static, dynamic, anticipatory, and reactive components. Exercises included heel-to-toe standing, single-leg stance, tandem stance, obstacle walking, heel-to-toe walking, side stepping, functional reach, weight shifting, caregiver-assisted perturbations, and foam surface standing. All exercises were performed in 3 sets with specified holds or repetitions. Sessions concluded with cool-down activities including tricep stretches, forward bends, and deep breathing.

  • OtherTraditional balance training group

    Same as telerehabilitation group but it will concluded in a clinical setting.

06

What researchers measure

Primary outcomes

  1. Change in Berg Balance Scale score

    The Berg Balance Scale (BBS) is a widely used clinical tool to assess static and dynamic balance in individuals, particularly older adults. It's a 14-item test that evaluates a person's ability to perform various balance-related tasks, such as sitting, standing, reaching, and turning. Each item is scored on a 0-4 scale, with 0 indicating the lowest level of function and 4 indicating the highest. The total score ranges from 0 to 56, with lower scores suggesting a higher risk of falls

    Time frame: Baseline and 6 weeks

Secondary outcomes

  1. Change in Time up and Go test score

    The Timed Up and Go Test (TUG) is a simple yet widely validated tool used to assess mobility and fall risk. It measures how quickly an individual can rise from a chair, walk three meters, turn, walk back, and sit down

    Time frame: Baseline and 6 weeks

  2. Functional reach test

    The Functional Reach Test (FRT) assesses how far an individual can reach forward while standing, without stepping or losing balance. It's particularly effective for identifying balance limitations in frail or elderly populations

    Time frame: Baseline and 6 weeks

  3. Change in Push and release test score

    Push and Release Test is designed to measure reactive postural control by observing how a person recovers after being released from a supported backward lean.

    Time frame: Baseline and 6 weeks

  4. Change in Single leg stance test score

    The Single Leg Stance Test (SLS) is a simple but powerful tool to evaluate balance and stability, particularly in older adults or individuals with conditions like osteoporosis. In this test, the person is asked to stand on one leg usually with eyes open and hands on hips while the clinician times how long they can maintain that position without support. It's an effective way to spot balance problems that could lead to falls

    Time frame: Baseline and 6 weeks

07

Study locations

1 site
  • Riphah International Hospital
    Islamabad, ICT, Pakistan
08

References and documents

Publications

  • Li S, Li Y, Liang Q, Yang WJ, Zi R, Wu X, Du C, Jiang Y. Effects of tele-exercise rehabilitation intervention on women at high risk of osteoporotic fractures: study protocol for a randomised controlled trial. BMJ Open. 2022 Nov 7;12(11):e064328. doi: 10.1136/bmjopen-2022-064328. PubMed 36344002 ↗
  • Rezaei MK, Torkaman G, Bahrami F, Bayat N. The effect of six week virtual reality training on the improvement of functional balance in women with type-I osteoporosis: A preliminary study. Sport Sci Health. 2023;19(1):185-194. doi: 10.1007/s11332-022-01018-8. Epub 2022 Nov 15. PubMed 36408530 ↗
  • Wei F, Hu Z, He R, Wang Y. Effects of balance training on balance and fall efficacy in patients with Osteoporosis: A systematic review and meta-analysis with trial sequential analysis. J Rehabil Med. 2023 May 17;55:jrm00390. doi: 10.2340/jrm.v55.4529. PubMed 37194565 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2026; primary completion for Jun 2026, 5 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2025
First posted
Aug 29, 2025
StartEst.
Jan 2026
Primary completionEst.
Jun 2026
CompletionEst.
Jul 2026
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07148479
Responsible party
Sponsor
First posted
Aug 29, 2025
Start date
Jan 2026 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Aug 27, 2026

Study contacts

Prof. Dr. Huma Riaz
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion